Short Sellers Become More Focused in Major Biotechs
The short interest data are out for the August 14 settlement date. Biotech companies are considered a riskier group of stocks.
All Work
Chris Lange
Short Sellers Run for Cover on Semiconductors
The short interest data have come out for the August 14 settlement date. On the whole, short sellers appear to be backing off semiconductor stocks.
Short Sellers Have Mixed Feelings on Major Pharma
The August 14 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short interest is mixed.
Short Sellers Become More Selective on Major Oil Stocks
The short interest data have been released for the August 14 settlement date. It just so happens that some of the latest short interest readings for major oil companies are backing off highs.
Century Aluminum Issues Warning
ThinkstockCentury Aluminum Co. (NASDAQ: CENX) is making waves in the after-hours trading session following the release of a warning for a potential closure. The company issued a notice to employees at its Hawesville, Kentucky,…
Digital Ally Authorizes New Buyback Plan
ThinkstockDigital Ally Inc. (NASDAQ: DGLY) announced that its board of directors approved a stock buy-back program authorizing the company to purchase up to $2.5 million of outstanding common shares. For some background on Digital…
Mylan Fires Back at Perrigo
Mylan announced Tuesday, in conjunction with the Irish Takeover Panel, that Perrigo had made misleading statements to shareholders.
2 Bargain Home Improvement Stocks After the Sell-Off
Argus sees the sell-off as as an opportunity to establish positions in high-quality "redemption casualties" that have been dragged down on nonfundamental weakness, such as Lowe's and Masco.
Nabriva Files for IPO
Nabriva Therapeutics has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Key Analyst Sees Attractive Entry Into Euronav
Considering falling oil prices and the cost that it takes to store oil, Euronav appears to be well positioned.
What a Key Analyst Has to Say About Southern Company’s Acquisition
Credit Suisse appreciates the longer-term motivations behind Southern Company's deal to acquire AGL Resources.
Why Wells Fargo Is Upgrading Apple Now
The broad markets were left in shambles on Monday as both the Dow and S&P sold off significantly. However this may have created a buying opportunity.
Allegiance Bancshares Files for IPO
Allegiance Bancshares has filed with the Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Epizyme Beats Out the Market With FDA Approval
Epizyme survived the market carnage of Monday morning’s trading session. In fact this biopharma came out of the fray better off than when it went in.
HMS Runs on State of New York Contract
ThinkstockHMS Holdings Corp. (NASDAQ: HMSY) is winning in the market Monday despite all the turmoil and volatility that tanked the market earlier. Only recently did this company reported earnings at the tail end of…
What to Expect From Best Buy Earnings
Best Buy is scheduled to report its fiscal second-quarter financial results Tuesday before the markets open.
Key Analyst Sees Bank of America Rising 25% Despite Downturn
After the huge sell-off on Monday, KBW does not know how long the market carnage will last. In the meantime it is upgrading Bank of America to an Outperform rating.
5 Stocks Bucking or Surviving the Market Selling Trend on Monday
The market carnage appears to be subsiding. 24/7 Wall St. has compiled a list of a few companies that are bucking the presiding trends.
Despite Market Tank, Why Merrill Lynch Made Major Oil Upgrade
The markets were absolutely crumbling in Monday’s trading session, with the Dow down near 1,000 points and the S&P down around 90 points.
The Shanghai Carnage
24/7 Wall St. has taken a few key exchange traded funds and stocks from the Chinese markets that are representative of the recent plunge.